期刊文献+

自噬在心血管疾病中作用的研究进展 被引量:4

Roles of autophagy in cardiovascular diseases:research progression
原文传递
导出
摘要 我国心血管疾病发病率和病死率高,严重威胁人们的健康和生存质量。自噬参与多种心血管疾病的发生,影响心脏功能的维持和疾病的预后,可能成为心血管疾病新的治疗靶点。现对自噬在冠心病、心肌肥厚、心力衰竭和心律失常等多种心脏疾病中作用的研究进展进行归纳总结。 The morbidity and mortality of cardiovascular diseases(CVD)are still high in our country, they severely threaten peoples health and quality of life. A dysregulated or reduced autophagy is associated with ischemic heart disease,cardiac hypertrophy,heart failure and arrhythmia. Autophagy is a key regulator in CVD development, and is essential for maintenance of heart function and improvement of prognosis. Thus, modulating autophagy represents an attractive future therapeutic target for treating cardiovascular disease. This article reviewed the research progression about effects of autophagy on ischemic heart disease,cardiac hypertrophy,heart failure and arrhythmia.
作者 杜玲 何青
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2017年第5期589-593,共5页 Chinese Journal of Geriatrics
基金 首都市民健康计划(Z131100004013032) 北京医院临床研究121工程资助项目(121-2016004)
关键词 心血管疾病 自噬 Cardiovascular diseases Autophagy
  • 相关文献

参考文献1

二级参考文献29

  • 1Frohlich ED,Apstein C,Chobanian AV,Devereux RB,Dustan HP,Dzau V,et al.The heart in hypertension.N Engl J Med 1992,327:998-1008.
  • 2Dahlof B,Devereux RB,Kjeldsen SE,Julius S,Beevers G,de Faire U,et al.Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study(LIFE):a randomised trial against atenolol.Lancet 2002,359:995-1003.
  • 3de Simone G,Gottdiener JS,Chinali M,Maurer MS.Left ventricular mass predicts heart failure not related to previous myocardial infarction:the Cardiovascular Health Study.Eur Heart J 2008,29:741-7.
  • 4Roger VL,Go AS,Lloyd-Jones DM,Benjamin El,Berry JD,Borden WB,et al.Heart disease and stroke statistics-2012 update:a report from the American Heart Association.Circulation 2012,125:e2-e220.
  • 5Frey N,Olson EN.Cardiac hypertrophy:the good,the bad,and the ugly.Annu Rev Physiol 2003,65:45-79.
  • 6Kjeldsen SE,Dahlof B,Devereux RB,Julius S,Aurup P,Edelman J,et al.Effects of Iosartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy:a Losartan Intervention for Endpoint Reduction(LIFE)substudy.JAMA 2002,288:1491-8.
  • 7Lang CC,Struthers AD.Targeting the renin-angiotensin-aldosterone system in heart failure.Nat Rev Cardio12013,10:125-34.
  • 8Siragy HM.Rationale for combininga direct renin inhibitor with other renin-angiotensin system blockers.Focus on aliskiren and combinations.Cardiovasc Drugs Ther 2011,25:87-97.
  • 9Shah AM,Shin SH,Takeuchi M,Skali H,Desai AS,Kober L,et al.Left ventricular systolic and diastolic function,remodelling,and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren.Eur J Heart Failure 2012:14:185-92.
  • 10Harel Z,Gilbert C,Wald R,Bell C,Perl J,Juurlink D,et al.The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury:systematic review and meta-analysis.BMJ 2012,344:e42.

共引文献11

同被引文献33

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部